Money Makers Mentor

Precedent Transactions Healthcare, 2nd Quarter 2020

The Covid-19 Pandemic has significantly impacted the healthcare sector, as the virus continues to spread around many areas of the world. However, this did not stop some major deals from taking place in Q2 of 2020. Below are the seven largest deals in the healthcare sector from Q2 of 2020.

UCB Completes Acquisition of Ra Pharmaceuticals

UCB (UCB.BR) acquired Ra Pharmaceuticals (RARX), announcing the completion of the acquisition on April 2, 2020. The transaction was originally announced on October 10, 2019, with the intention of improving treatment options for people living with rare diseases. The total cash value of the deal is approximately $2.3 billion/2.1 billion euros. This value is based on $48 in cash per Ra Pharma share. The value also takes any expenses associated with sett…

Leave A Reply

Your email address will not be published.